Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Semma Therapeutics

Semma Therapeutics
2014 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Series B LATEST DEAL TYPE
$114M LATEST DEAL AMOUNT
13 INVESTORS
Description

Developer of trans-formative therapies designed to eliminate the use of insulin injections for type 1 diabetes patients. The company's trans-formative therapies is a cell-based therapy for diabetes which traditionally requires use of an invasive insulin pump or multiple daily insulin injections combining proprietary cells with a state-of-the-art device to provide a replacement for the missing beta cells in a diabetic patient without immunosuppression.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • 450 Kendall Street
  • Suite 2B
  • Cambridge, MA 02142
  • United States

+1 (857) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Semma Therapeutics’s full profile, request a free trial.

Semma Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series B) 30-Nov-2017 $114M 00000 Completed Product Development
2. Grant 12-Sep-2016 000 0000 Completed Product Development
1. Early Stage VC (Series A) 24-Mar-2015 $44M $44M 000.00 Completed Product Development
To view this company’s complete deal history including valuation and funding, request access »

Semma Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

Semma Therapeutics Competitors (31)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Humacyte Venture Capital-Backed Durham, NC 00 00000 000000000000 00000
0000 000000 Formerly VC-backed Santa Monica, CA 000 00000 000000&0 00000
0000000 Venture Capital-Backed San Diego, CA 00 00000 00000000000 00000
000000000000 00000 Venture Capital-Backed Madison, WI 00.000 0000000000 0 00.000
0000 000000000000 Formerly VC-backed San Diego, CA 000 00000 00000000000 00000
To view this company’s complete list of competitors, request access »

Semma Therapeutics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 16-Nov-2015 000000000000000000 Therapeutic Devices 0000000 000000 00.0
To view this company’s complete investment and acquisition history, request access »

Semma Therapeutics Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
6 Dimensions Capital Venture Capital Minority 000 0000 000000 0
Cowen Group Investment Bank Minority 000 0000 000000 0
Eight Roads Venture Capital Minority 000 0000 000000 0
ORI Capital Venture Capital Minority 000 0000 000000 0
Sinopharm Capital PE/Buyout Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »

Semma Therapeutics Executive Team (12)

Name Title Board
Seat
Contact
Info
Bastiano Sanna Ph.D Chief Executive Officer & President
Elizabeth Stoner MD Interim Chief Executive Officer
Moses Goddard MD Chief Marketing Officer
Briannan Bintz Director of Delivery
Felicia Pagliuca Ph.D Vice President, Cell Biology and Research & Development and Co-Founder

1 Former Executive

You’re viewing 5 of 12 executives. Get the full list »

Semma Therapeutics Board Members (12)

Name Representing Role Since Contact
Info
Daniel Auerbach Eight Roads Board Member 000 0000
David Neustaedter Ph.D Medtronic Board Observer 000 0000
Douglas Melton Ph.D Semma Therapeutics Scientific Co-Founder and Board Observer 000 0000
James Scopa JD MPM Capital Board Member 000 0000
Kevin Raidy Cowen Group Board Member 000 0000

2 Former Board Members

You’re viewing 5 of 12 board members. Get the full list »